ZLAB — Zai Lab Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1704292 ·
China
Last close
$24.81
Market Cap
$2.79B
52W High
$33.65
52W Low
$15.96
ADV30
826,034
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 106,311,000 | 58,149,000 | -76,489,000 | -50,825,000 | 1,074,793,000 | 607,522,000 | 467,756,000 |
| Mar 2026 | 99,611,000 | 61,276,000 | -69,279,000 | -51,016,000 | 1,095,737,000 | 651,316,000 | 433,756,000 |
| Dec 2025 | 127,597,000 | 65,266,000 | -68,264,000 | -50,409,000 | 1,172,384,000 | 679,573,000 | 456,884,000 |
| Sep 2025 | 116,095,000 | 69,212,000 | -47,968,000 | -35,963,000 | 1,158,940,000 | 717,155,000 | 398,995,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-133,384,000
Investing CF
$-39,050,000
Financing CF
$44,641,000
CapEx
$-29,134,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.80
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,730,461,000
Inventory
$90,890,000
Receivables
$72,990,000
ST Investments
$10,000,000
EBIT TTM
$-184,737,000
Pretax Income TTM
$-190,722,000
Interest Exp TTM
$5,985,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$449,614,016
EBITDA
$-248,168,000
Free Cash Flow
$-83,963,752
Enterprise Value
$2,347,160,832
Total Cash
$617,521,984
Total Debt
$254,576,000
Shares Out
112,266,228
Trailing EPS
$-1.70
Book Value
$5.41
ROE
-26.9%
ROA
-14.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 460,156,000 | -223,572,000 | -175,537,000 | 1,172,384,000 | 456,884,000 | 715,500,000 | -150,789,000 |
| Dec 2024 | 398,988,000 | -273,947,000 | -257,103,000 | 1,185,753,000 | 344,855,000 | 840,898,000 | -214,869,000 |
| Dec 2023 | 266,719,000 | -374,140,000 | -334,620,000 | 1,036,295,000 | 240,177,000 | 796,118,000 | -198,178,000 |
| Dec 2022 | 215,040,000 | -392,886,000 | -443,286,000 | 1,220,140,000 | 174,545,000 | 1,045,595,000 | -367,642,000 |
TTM Snapshot
Revenues TTM
$453,280,000
NetIncome TTM
$-178,115,000
OpCashFlow TTM
—
Assets (Latest)
$1,095,737,000
Forward EPS
$-2.11
Max Pain — expiry 2027-01-15
max pain strike: $25.00 · spot: $25.16 · call oi: 3,737 · put oi: 2,817
Expected Move to 2027-01-15:
±$6.25
(24.85%) —
implied range
$18.91 –
$31.41
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PGEN | PRECIGEN, INC. | $2.72B | $7.60 | — |
| ELVN | Enliven Therapeutics, Inc. | $2.98B | $40.63 | — |
| RCUS | Arcus Biosciences, Inc. | $3.00B | $23.83 | — |
| MBX | MBX Biosciences, Inc. | $2.56B | $53.25 | — |
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.03B | $27.20 | — |
News headlines (Yahoo Finance, 1h cache)
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
2026-10-06 14:54 · Yahoo
Is Zai Lab (ZLAB) Cheap After Its ESMO 2026 Lung Cancer Data Update?
2026-10-04 03:09 · Yahoo
Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
2026-09-29 11:00 · Yahoo
Zai Lab (ZLAB) Stock Looks Stretched On Sales But Reasonable On Broader Checks
2026-09-06 18:11 · Yahoo
Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes Therapeutics
2026-08-20 15:30 · Yahoo
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
2026-08-18 07:00 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
2026-10-08 14:42 · Yahoo
Big Pharma Is Pouring Billions Into China’s Biotechs
2026-09-14 07:59 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 2% for Week
2026-08-28 14:37 · Yahoo
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
2026-10-09 01:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.